TODD STRATEGY GROUP

Lobbying for GENMAB · Biotech company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Health Issues

Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022.

Medicare/Medicaid

General Medicare/Medicaid Issues. 340B Issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.